EDT Pharmaceuticals and Par Pharmaceuticals filed suit against TWI Pharmaceuticals over a patent related to nanoparticulate megestrol formulations. 9/1, District of Maryland, 1:2011cv02466.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
